#22: Global Reimbursement Systems: A Market Access Perspective Day & Time:
June 23, 8:30AM - 12:00PMRoom Number:
John Brennick, MPA
Director, Worldwide Market Access
Janssen Global Services, LLC, United StatesDescription:Maximize your learning while attending the DIA 2013 49th Annual Meeting! Receive $100 off of your DIA 2013 meeting registration by registering for two half day tutorials or one full day tutorial. Purchases must be made at the same time in order to receive the discount.
Reimbursement approvals from payers (reimbursers) have become as important as regulatory approvals for pharmaceutical product success and providing access to patients. Even with reimbursement approval, payer restrictions such as step edits and individual patient approval significantly impact product usage. This tutorial will provide an overview of global reimbursement systems including health technology assessments (eg, NICE), and discuss ways in which evidence of value from clinical trials can help or limit market access.
|#22: Global Reimbursement Systems||IACET||3.25||0.300|
At the conclusion of this tutorial, participants should be able to:
• Summarize the evidence demands of global payer customers
• Discuss the growing importance of the reimbursement hurdle to patient access to your medicine
• Recognize how aspects of clinical trial design, such as dosing and comparator choice, can impact reimbursement potential.Target Audience:
This tutorial is designed for pharmaceutical industry employees not familiar with market access (pricing, reimbursement, health economics) issues.